PPACMAN Consensus Recs. for CV risk in PSO/PSA published for Rheums/Derms/PCPs - check BP, Wt, Lipids, Cr. - Look for H

Tweet Author

Tweet Content

PPACMAN Consensus Recs. for CV risk in PSO/PSA published for Rheums/Derms/PCPs - check BP, Wt, Lipids, Cr. - Look for HTN, DM, smoking, obesity, metabolic synd. - Risk stratify w/ hsCRP, Lipids - Lifestyle management https://t.co/MkgYopTNAX https://t.co/fplKbua9Z2

Links

Practical Recommendations on Cardiovascular Risk Evaluation in Patients With Ps… https://buff.ly/ZyCS3PJ

MTX Fails Knee OA (6.6.2025)

Review of ARF & Post-streptococcal reactive arthritis (PSRA) following Group A strept infxn. Early Dx & Rx of S

Tweet Author

RheumNow

Tweet Content

Review of ARF & Post-streptococcal reactive arthritis (PSRA) following Group A strept infxn. Early Dx & Rx of Strept can prevent ARF & PSRA. PSRA is a sterile arthritis, bimodal age onset, lower extrem arthritis, usually resolves without lasting sequelae https://t.co/ld208yf0Zk

Links

https://buff.ly/T45xOw7

Target trial emulation study data from British Dermatologists Biologics & Immunomodulators Register, compared 231 P

Tweet Author

RheumNow

Tweet Content

Target trial emulation study data from British Dermatologists Biologics & Immunomodulators Register, compared 231 PSO Rx w/ MTX + Adalimumab against 1553 PSO on ADA. @1Yr MTX did not augment ADA only responses based on Rx survival (79% vs 78%) or PASI75 (49% vs 52%). https://t.co/DSYNd9P5Om

Denosumab and Osteoporosis - A JAMA Review An overview of denosumab use in osteoporosis (OP) by Bauer and Ensrud was

Tweet Author

RheumNow

Tweet Content

Denosumab and Osteoporosis - A JAMA Review An overview of denosumab use in osteoporosis (OP) by Bauer and Ensrud was published in JAMA https://t.co/3d7Q61nVKM https://t.co/PdI235k9jh

Links

Denosumab and Osteoporosis - A JAMA Review | RheumNow https://buff.ly/sdcxvuT

5 June 2025

HLA-B27 Testing in Practice

Analysis of testing for human leukocyte antigen B27 (HLA-B27) in a teaching center shows HLA-B27 testing was frequently performed by rheumatologists and nonrheumatologists for a broad spectrum of indications and primarily as a screening test.

Data derived from the Mass General Brigham healthcare system, examined HLA-B27 testing and clinical associations between 1/1/2022 to 12/31/2022. Rheumatology referrals were calculated for HLA-B27 positive and negative patients.

5 June 2025

Psoriatic Arthritis at Risk for Interstitial Lung Disease

A TriNetX EHR study shows that psoriatic arthritis, but not psoriasis, patients are at increased risk for interstitial lung disease (ILD).

Global incidence of alopecia areata increased betw 1990 - 2021; from 20.43 million (19.77-21.09 million) in 1990 to 30.8

Tweet Author

RheumNow

Tweet Content

Global incidence of alopecia areata increased betw 1990 - 2021; from 20.43 million (19.77-21.09 million) in 1990 to 30.89 million in 2021 ( range of 29.95-31.82 million) - highest in USA 550/100,000. High in N.America, S.America, Southeast Asia, Australia. Lowestin Africa, Middle https://t.co/d3WA3CRFRC

Review of Emerging Treatments for Vitiligo an immune mediated dz that affects QOL & has psychosocial impact. JAKi o

Tweet Author

RheumNow

Tweet Content

Review of Emerging Treatments for Vitiligo an immune mediated dz that affects QOL & has psychosocial impact. JAKi only ruxolitinib is FDA-approved, but Tofa & Bari show promise. Emerging therapies include simvastatin, afamelanotide, and metformin https://t.co/Rp2yYx6SyZ https://t.co/pBo1IDe8pQ

Links

Future of Vitiligo Treatment: Emerging Therapies, Impact on Quality of Life https://buff.ly/o1KU3AH

Save the date! RheumNow will be at EULAR '25 June 11-14. https://t.co/J0dq4PWf6q

Tweet Author

RheumNow

Tweet Content

Save the date! RheumNow will be at EULAR '25 June 11-14. https://t.co/J0dq4PWf6q

Topics

PPACMAN Consensus Recs. for CV risk in PSO/PSA published for Rheums/Derms/PCPs - check BP, Wt, Lipids, Cr. - Look for H

MTX Fails Knee OA (6.6.2025)

Review of ARF & Post-streptococcal reactive arthritis (PSRA) following Group A strept infxn. Early Dx & Rx of S

Target trial emulation study data from British Dermatologists Biologics & Immunomodulators Register, compared 231 P

Denosumab and Osteoporosis - A JAMA Review An overview of denosumab use in osteoporosis (OP) by Bauer and Ensrud was

Global incidence of alopecia areata increased betw 1990 - 2021; from 20.43 million (19.77-21.09 million) in 1990 to 30.8

Review of Emerging Treatments for Vitiligo an immune mediated dz that affects QOL & has psychosocial impact. JAKi o

Save the date! RheumNow will be at EULAR '25 June 11-14. https://t.co/J0dq4PWf6q

Do you get our email newsletter?